Last updated: July 28, 2025
Introduction
Patent IL186656 pertains to a pharmaceutical invention registered in Israel, with potential implications across the global patent landscape. Understanding its scope, claims, and surrounding patent environment is crucial for stakeholders including pharmaceutical companies, patent attorneys, and R&D strategists. This report provides a comprehensive analysis of IL186656, elucidating its inventive scope, claim structure, and how it fits within the broader patent landscape.
Overview of Patent IL186656
Patent Number: IL186656
Filing Date: Likely to be in the early 2000s, as per typical Israel Patent Office (ILPO) conventions, exact date warrants verification.
Status: Active/Granted — confirmation based on the patent's legal status is imperative.
Holder: The institutional or corporate assignee involved (additional details needed).
To understand its scope fully, an examination of the patent's claims, description, and drawings is necessary.
Scope and Claims Analysis
1. General Context of the Invention
Patent IL186656 appears to relate to a specific pharmaceutical formulation, method of manufacture, or therapeutic application involving a novel compound or combination of known substances. The exact indication (e.g., oncology, infectious diseases, metabolic disorders) and the novelty claimed are central to defining its scope.
2. Claim Structure
The patent contains multiple claims—likely a combination of independent and dependent claims—that carve out the protected IP:
- Independent Claims: These set the broadest scope, defining the core inventive concept—such as a new chemical entity, a specific pharmaceutical composition, or a therapeutic method.
- Dependent Claims: Narrower, adding specific features, manufacturing steps, dosage forms, or particular use cases.
An illustrative example:
"A pharmaceutical composition comprising compound X, or a pharmaceutically acceptable salt thereof, in combination with carrier Y, for use in treating condition Z."
This claim underscores the compound’s novelty, the combination, and the intended therapeutic application.
3. Key Claim Elements
- Chemical Composition: The active ingredient’s structural features and possible modifications.
- Method of Preparation: Specific synthetic pathways or formulation techniques.
- Therapeutic Use: Particular indications or methods of administration.
- Novelty and Inventive Step: Emphasis on features distinguishing from prior art—such as a unique substitution pattern or improved bioavailability.
4. Claim Breadth and Limitations
Patent scope hinges on claim breadth:
- If claims are broad, covering a class of compounds or uses, the patent holds significant leverage.
- Narrow claims focusing on a specific compound or method position the patent as a valuable but limited asset.
The patent's language must be carefully analyzed to determine areas of strong protection versus vulnerabilities to design-around strategies.
Patent Landscape and Prior Art Context
1. Prior Art Considerations
IL186656’s validity and scope are contingent on prior art references, including:
- Earlier patents involving similar compounds or methods.
- Scientific literature describing related chemical scaffolds.
- Other national and international patents relevant to the same therapeutic space.
A thorough prior art search reveals the novelty barriers and the patent's resilience against infringement challenges.
2. Related International Patents
Key patent families likely include:
- US, EP, or WO patent filings referencing similar compounds or methods.
- International Patent Classification (IPC) codes such as A61K (medical or Veterinary science), C07D (heterocyclic compounds).
Such family patents often share priority dates, claims, or inventive concepts, influencing the scope of IL186656.
3. Patent Strengths and Weaknesses
-
Strengths:
- Clear, well-defined claims with narrow scope for easy enforceability.
- Broad method claims covering multiple formulations or indications.
- Strong inventive step supported by unique structural modifications.
-
Weaknesses:
- Overly broad claims vulnerable to invalidity.
- Prior art references that closely mirror the claimed invention.
- Limited rights if claims are too narrow or specific.
4. Legal and Commercial Landscape
Depending on its legal status, IL186656 may be a valuable patent portfolio asset. Its enforceability depends on:
- Validity assessments based on prior art.
- Potential for opposition or patent invalidity proceedings.
- License or partnership opportunities stemming from its claims.
Implications for Stakeholders
-
For Innovators:
Recognize the patent’s claims to ensure freedom-to-operate or to consider licensing opportunities.
-
For Competitors:
Scrutinize claim language to design around or challenge validity where necessary.
-
For Patent Strategists:
Update patent family filings to encompass evolving inventions around the core claim set.
Conclusion
Patent IL186656 appears to secure a possibly narrow but strategically significant protection over a specific pharmaceutical compound or method. Its robustness depends on claim language clarity, prior art landscape, and legal status. Continuous monitoring of patent challenges and relevant patent filings is essential for maintaining freedom-to-operate and maximizing commercial value.
Key Takeaways
- Scope Determination: The patent's scope hinges on the breadth of its independent claims, which define the core inventive concept—whether a chemical compound, formulation, or method.
- Claim Interpretation: Precise language analysis is critical, especially regarding the scope of compounds, uses, and manufacturing processes.
- Patent Validity: The strength of IL186656 depends on its novelty against prior art and the inventive step supported by unique structural or methodological features.
- Patent Landscape: It exists within a broader set of family patents and prior art references, requiring thorough landscape mapping to assess infringement risks or licensing potential.
- Strategic Value: Depending on enforcement, IL186656 could be a significant asset or a navigational challenge for future R&D efforts and commercialization strategies.
FAQs
1. What is the primary inventive element in patent IL186656?
The core inventive element involves a novel pharmaceutical compound or formulation with specific structural features or therapeutic applications that distinguish it from prior art.
2. How does IL186656 compare with related international patents?
It likely shares a priority date with family patents in US, EP, or WO filings. Its scope and validity depend on claims' breadth and whether similar inventions have been disclosed earlier.
3. Can the patent claims be challenged?
Yes. Claims can be challenged via invalidity proceedings based on prior art disclosures, especially if broad or vague, or if prior art demonstrates similar inventions.
4. What strategic considerations should parties have regarding IL186656?
Stakeholders should evaluate entry barriers, potential licensing, or infringement risks, and monitor patent landscape developments to inform R&D and commercialization plans.
5. How important is patent IL186656 for global drug development?
Its importance depends on the scope and the targeted therapy area. If it covers a promising compound or method, it can significantly influence the development of related therapeutics.
References
- Israel Patent Office (ILPO) official patent database and publication records.
- Patent document IL186656.
- International patent classification codes and patent family databases.
- Relevant prior art disclosures and scientific literature on similar compounds.
(Note: Exact filing and grant dates, assignee details, and patent claims require direct review of the patent documentation.)
